Dimensional Fund Advisors
NGNE icon

Dimensional Fund Advisors’s Neurogene NGNE Stock Holding History

Dimensional Fund Advisors’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$230K Buy
11,415
+5
+0% +$97 ﹤0.01% 3054
2025
Q4 		$235K Buy
+11,410
New +$284K ﹤0.01% 3072
2023
Q1 		– Sell
-518
Closed -$5 – 3490
2022
Q4 		$5 Hold
518
– – ﹤0.01% 3490
2022
Q3 		$7K Sell
518
-561
-52% -$11.4K ﹤0.01% 3485
2022
Q2 		$22K Hold
1,079
– – ﹤0.01% 3440
2022
Q1 		$41K Sell
1,079
-393
-27% -$22.9K ﹤0.01% 3472
2021
Q4 		$142K Buy
1,472
+315
+27% +$38.4K ﹤0.01% 3395
2021
Q3 		$167K Sell
1,157
-700
-38% -$107K ﹤0.01% 3374
2021
Q2 		$343K Buy
1,857
+1,124
+153% +$249K ﹤0.01% 3236
2021
Q1 		$180K Sell
733
-11,437
-94% -$2.92M ﹤0.01% 3301
2020
Q4 		$3.43M Sell
12,170
-3,528
-22% -$862K ﹤0.01% 2649
2020
Q3 		$3.77M Sell
15,698
-5,030
-24% -$1.22M ﹤0.01% 2544
2020
Q2 		$6.88M Sell
20,728
-597
-3% -$156K ﹤0.01% 2351
2020
Q1 		$4.85M Sell
21,325
-665
-3% -$137K ﹤0.01% 2419
2019
Q4 		$5.42M Buy
21,990
+2,169
+11% +$216K ﹤0.01% 2584
2019
Q3 		$1.13M Buy
19,821
+155
+0.8% +$9.46K ﹤0.01% 2983
2019
Q2 		$928K Hold
19,666
– – ﹤0.01% 3069
2019
Q1 		$1.06M Buy
19,666
+2,166
+12% +$109K ﹤0.01% 3020
2018
Q4 		$756K Buy
17,500
+3,736
+27% +$182K ﹤0.01% 3080
2018
Q3 		$807K Buy
13,764
+10,125
+278% +$597K ﹤0.01% 3108
2018
Q2 		$193K Hold
3,639
– – ﹤0.01% 3257
2018
Q1 		$1.02M Buy
3,639
+2,157
+146% +$596K ﹤0.01% 2994
2017
Q4 		$349K Buy
+1,482
New +$347K ﹤0.01% 3144

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Dimensional Fund Advisors's NGNE Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Neurogene (NGNE) stake by 0.04% in Q1 2026, buying an estimated $97 and bringing the position to 11,415 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #3054.

Dimensional Fund Advisors first reported a position in NGNE in Q4 2017 and has held it in 23 quarters since. The position peaked at $6.88M in Q2 2020. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • Dimensional Fund Advisors held 11,415 shares of Neurogene worth $230K as of Q1 2026.
  • Dimensional Fund Advisors bought 5 Neurogene shares in Q1 2026, an estimated $97.
  • Neurogene made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3054 holding.
  • Dimensional Fund Advisors first reported a position in Neurogene in Q4 2017 and has held it in 23 quarters since.
  • Dimensional Fund Advisors's Neurogene position peaked at $6.88M in Q2 2020.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.